TPGS-stabilized NaYbF4: ER Upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance

Biomaterials

Volumn 40, Issue , 2015, Pages 107-116

  Tian, Gan ^a,b   Zheng, Xiaopeng ^b,d   Zhang, Xiao ^b,c   Yin, Wenyan ^b   Yu, Jie ^b   Wang, Dongliang ^c   Zhang, Zhiping ^e   Yang, Xiangliang ^e   Gu, Zhanjun ^b   Zhao, Yuliang ^a,b,c  

^a SICHUAN UNIVERSITY   (China)

^b INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^c NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Multi drug resistance; P gp inhibition; Theranostics; TPGS; Upconversion nanoparticles

Indexed keywords

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; DISEASES; DRUG PRODUCTS; ELECTRIC RESISTANCE; FLUORESCENCE IMAGING; GLYCOPROTEINS; NANOPARTICLES; ONCOLOGY; TARGETED DRUG DELIVERY; THERANOSTICS; X RAYS;

ANTI-CANCER DRUG DELIVERY; MULTIDRUG RESISTANCE; TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATES; TPGS; UP-CONVERSION EMISSION; UPCONVERSION LUMINESCENCE; UPCONVERSION NANOPARTICLES; X-RAY COMPUTED TOMOGRAPHY;

CONTROLLED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; DOXORUBICIN; ERBIUM; MULTIDRUG RESISTANCE PROTEIN; NANOPARTICLE; TOCOFERSOLAN; YTTERBIUM; ALPHA TOCOPHEROL; ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; MACROGOL DERIVATIVE; OLEIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; FLOW CYTOMETRY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; LUMINESCENCE; MCF 7 CELL LINE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION; SOLUBILITY; WESTERN BLOTTING; X RAY; ANALOGS AND DERIVATIVES; ANIMAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FLUORESCENCE; INFRARED SPECTROSCOPY; METABOLISM; NUDE MOUSE; THERMOGRAVIMETRY; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; FLUORESCENCE; HUMANS; LUMINESCENCE; MCF-7 CELLS; MICE, NUDE; NANOPARTICLES; OLEIC ACID; P-GLYCOPROTEINS; POLYETHYLENE GLYCOLS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMOGRAVIMETRY; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN E; YTTERBIUM;

EID: 84919683158     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.11.022     Document Type: Article

References (50)

1. Chabner B.A., Roberts T.G. Chemotherapy and the war on cancer. Nat Rev Cancer 2005, 5:65-72.
2. Bailly C. Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy. Chem Rev 2012, 112:3611-3640.
3. Shi Z., Tiwari A.K., Patel A.S., Fu L.W., Chen Z.S. Roles of sildenafil in enhancing drug sensitivity in cancer. Cancer Res 2011, 71:3735-3738.
4. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002, 2:48-58.
5. Gao J., Feng S.S., Guo Y. Nanomedicine against multidrug resistance in cancer treatment. Nanomedicine 2012, 7:465-468.
6. Wang L.M., Lin X.Y., Wang J., Hu Z.J., Ji Y.L., Hou S., et al. Novel insights into combating cancer chemotherapy resistance using a plasmonic nanocarrier: enhancing drug sensitiveness and accumulation simultaneously with localized mild photothermal stimulus of femtosecond pulsed laser. Adv Funct Mater 2014, 24:4229-4242.
7. Wu C.P., Hsieh C.H., Wu Y.S. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Mol Pharm 2011, 8:1996-2011.
8. Szakács G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006, 5:219-234.
9. Fletcher J.I., Haber M., Henderson M.J., Norris M.D. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 2010, 10:147-156.
10. Bogman K., Erne-Brand F., Alsenz J., Drewe J. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. JPharm Sci 2003, 92:1250-1261.
11. Miller D.W., Batrakova E.V., Kabanov A.V. Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers. Pharm Res 1999, 16:396-401.
12. Dintaman J.M., Silverman J.A. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999, 16:1550-1556.
13. Shen J.N., Yin Q., Chen L.L., Zhang Z.W., Li Y.P. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer. Biomaterials 2012, 33:8613-8624.
14. Zhang Z.P., Lin M., Feng S.S. Vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine. Nanomedicine 2012, 7:1645-1647.
15. Guo Y.Y., Chu M., Tan S.W., Zhao S., Liu H.X., Otieno B.O., et al. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Mol Pharm 2014, 11:59-70.
16. Cao N., Feng S.S. Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, invitro and invivo evaluation. Biomaterials 2008, 29:3856-3865.
17. Doane T.L., Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 2012, 41:2885-2911.
18. Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2012, 64:24-36.
19. Yang K., Feng L.Z., Shi X.Z., Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev 2013, 42:530-547.
20. Zhou J., Liu Z., Li F.Y. Upconversion nanophosphors for small-animal imaging. Chem Soc Rev 2012, 41:1323-1349.
21. Gu Z.J., Yan L., Tian G., Li S.J., Chai Z.F., Zhao Y.L. Recent advances in design and fabrication of upconversion nanoparticles and their safe theranostic applications. Adv Mater 2013, 25:3758-3779.
22. Feng W., Han C.M., Li F.Y. Upconversion-nanophosphor-based functional nanocomposites. Adv Mater 2013, 25:5287-5303.
23. Liu Y.S., Tu D.T., Zhu H.M., Chen X.Y. Lanthanide-doped luminescent nanoprobes: controlled synthesis, optical spectroscopy, and bioapplications. Chem Soc Rev 2013, 42:6924-6958.
24. 5-based upconversion nanoparticles as drug carriers and multimodal imaging probes. Biomaterials 2014, 35:2011-2023.
25. Liu J.N., Bu W.B., Pan L.M., Shi J.L. NIR-triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene-modified mesoporous silica. Angew Chem Int Ed 2013, 52:4375-4379.
26. Yuan Y.Y., Min Y.Z., Hu Q.L., Xing B.G., Liu B. NIR photoregulated chemo- and photodynamic cancer therapy based on conjugated polyelectrolyte-drug conjugate encapsulated upconversion nanoparticles. Nanoscale 2014, 6:11259-11272.
27. 3+)-based upconversion nanomaterials for drug delivery. Chem Soc Rev 2014, 10.1039/c4cs00155a.
28. Yan Y., Björnmalm M., Caruso F. Particle carriers for combating multidrug-resistant Cancer. ACS Nano 2013, 7:9512-9517.
29. Chandrasekharan P., Maity D., Yong C.X., Chuang K.H., Ding J., Feng S.S. Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI. Biomaterials 2011, 32:5663-5672.
30. Aw M.S., Addai-Mensah J., Losic D. Amulti-drug delivery system with sequential release using titania nanotube arrays. Chem Commun 2012, 48:3348-3350.
31. Lai S.M., Hsiao J.K., Yu H.P., Lu C.W., Huang C.C., Shieh M.J., et al. Polyethylene glycol-based biocompatible and highly stable superparamagnetic iron oxide nanoclusters for magnetic resonance imaging. JMater Chem 2012, 22:15160-15167.
32. Mi Y., Liu X.L., Zhao J., Ding J., Feng S.S. Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. Biomaterials 2012, 33:7519-7529.
33. Zhao J., Feng S.S. Effects of PEG tethering chain length of vitamin E TPGS with a Herceptin-functionalized nanoparticle formulation for targeted delivery of anticancer drugs. Biomaterials 2014, 35:3340-3347.
34. Kulkarni S.A., Feng S.S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res 2013, 30:2512-2522.
35. Cao T.Y., Yang Y., Sun Y., Wu Y.Q., Feng W., Cao Y., et al. Biodistribution of sub-10 nm PEG-modified radioactive/upconversion nanoparticles. Biomaterials 2013, 34:7127-7134.
36. Ni D.L., Zhang J.W., Bu W.B., Xing H.Y., Han F., Xiao Q.F., et al. Dual-targeting upconversion nanoprobes across the blood brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. ACS Nano 2014, 8:1231-1242.
37. Cen Y., Wu Y.M., Kong X.J., Wu S., Yu R.Q., Chu X. Phospholipid-modified upconversion nanoprobe for ratiometric fluorescence detection and imaging of phospholipase D in cell lysate and in living cells. Anal Chem 2014, 86:7119-7127.
38. Liu Y.L., Ai K.L., Lu L.H. Nanoparticulate X-ray computed tomography contrast agents: from design validation to invivo applications. Accounts Chem Res 2012, 45:1817-1827.
39. 3 up-conversion nanoparticle as an invivo X-Ray CT imaging contrast agent. Biomaterials 2012, 33:6748-6757.
40. Lee H., Choi S.H., Hyeon T. Nano-sized CT contrast agents. Adv Mater 2013, 25:2641-2660.
41. 4:Yb,Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012, 33:4618-4627.
42. 3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 2012, 33:5384-5393.
43. Tian G., Yin W.Y., Jin J.J., Zhang X., Xing G.M., Li S.J., et al. Engineered design of theranostic upconversion nanoparticles for tri-modal upconversion luminescence/magnetic resonance/X-ray computed tomography imaging and targeted delivery of combined anticancer drugs. JMater Chem B 2014, 2:1379-1389.
44. 4 upconversion nanoparticles by thermo-decomposition of rare-earth oleates. Cryst Eng Comm 2014, 16:5650-5661.
45. 4 microtubes: controlled synthesis and intense ultraviolet photoluminescence. JPhys Chem C 2010, 114:10750-10754.
46. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
47. 4:Yb/Er upconversion nanoparticles for invivo imaging and drug delivery. Adv Mater 2012, 24:1226-1231.
48. Gai S.L., Yang P.P., Li C.X., Wang W.X., Dai Y.L., Niu N., et al. Synthesis of magnetic, up-conversion luminescent, and mesoporous core-shell-structured nanocomposites as drug carriers. Adv Funct Mater 2010, 20:1166-1172.
49. 3+@hydrogel core-shell hybrid microspheres. ACS Nano 2012, 6:3327-3338.
50. Takemura Y., Kobayashi H., Miyachi H. Mechanisms of multidrug resistance in tumor cells and analytical methods for its detection. Jpn J Clin Pharmacol 1998, 46:745-758.